
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf is expected to have solid revenue growth and EBITDA improvement, driven by their focus on the banking and retail segments and strong product backlog/lead times. With a diversified portfolio and plans to reduce seasonality, as well as maintaining cost discipline and generating strong free cash flow, the company is set to see positive growth. While there are some potential risks, analysts overall remain bullish and continue to recommend a BUY rating for the stock.
Bears say
Diebold Nixdorf is facing several challenges, including a highly competitive market for its ATM and retail solutions, as well as threats from alternative products such as cryptocurrency. The company's reliance on the Banking segment for a majority of its revenue puts it at risk for any potential downturns in the financial industry. Additionally, the company's margin pressure and increased spending on new product launches may impact its profitability and lead to lower earnings and EPS in the near term.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares